As COVID-19 mitigation efforts decrease, influenza A/B transmission may increase. Experts believe both COVID-19 and influenza are expected to co-circulate this fall and winter.
While respiratory illnesses share similar symptoms, they are treated differently. The ability to detect both viruses is critical information for proper treatment. For some, an inaccurate diagnosis can have serious consequences.
Flow Health now offers a sensitive Influenza A/B and COVID-19 Combo PCR test that can detect and differentiate infections for any of the three respiratory viruses from a single sample. The test uses an assay design with two SARS-CoV-2 targets to compensate for emerging variants and mutations and to help provide confidence in results.
Symptomatic or exposed individuals can schedule a same-day appointment at any of our Patient Service Centers at no cost with any insurance.
(Not available at New Orleans and Chicago locations.)
Lab results are available in less than 24 hours. These results can be accessed by the patient or the provider from our secure Patient Portal app.
For more information about this specific test, contact cs@flowhealth.com.
FDA Instructions and Fact Sheet:
IFU: https://www.fda.gov/media/145931/download
Fact Sheet: https://www.fda.gov/media/145930/download
related blog posts
)-2.png)
.jpeg)
